Advances in the Management of Early-Stage Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with both inter- and intratumor heterogeneity, thought to result in a more aggressive course and worse outcomes. Neoadjuvant therapy (NAT) has become the preferred treatment modality of early-stage TNBC as it allows for the downstagi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhardwaj, Prarthna V., Wang, Yue, Brunk, Elizabeth, Spanheimer, Philip M., Abdou, Yara G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419523/
https://www.ncbi.nlm.nih.gov/pubmed/37569851
http://dx.doi.org/10.3390/ijms241512478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419523/
https://www.ncbi.nlm.nih.gov/pubmed/37569851
http://dx.doi.org/10.3390/ijms241512478

Ejemplares similares